BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8178449)

  • 21. Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.
    Sherman L; Yaniv A; Lichtman-Pleban H; Tronick SR; Gazit A
    J Virol; 1989 Nov; 63(11):4925-31. PubMed ID: 2552171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
    Jiang MC; Lin JK; Chen SS
    Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nuclear factor is required for transactivation of HTLV-I gene expression.
    Park RE; Haseltine WA; Rosen CA
    Oncogene; 1988 Sep; 3(3):275-9. PubMed ID: 2849741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent trans activation by Tat from the major immediate-early promoter of murine cytomegalovirus.
    Kim YS
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1152-9. PubMed ID: 8093034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells.
    Thatikunta P; Sawaya BE; Denisova L; Cole C; Yusibova G; Johnson EM; Khalili K; Amini S
    J Cell Biochem; 1997 Dec; 67(4):466-77. PubMed ID: 9383706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
    Liao HJ; Baker CC; Princler GL; Derse D
    Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Mol Cell Biol; 1999 Jul; 19(7):4592-9. PubMed ID: 10373508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological activity and intracellular location of the Tat protein of equine infectious anemia virus.
    Rosin-Arbesfeld R; Mashiah P; Willbold D; Rosch P; Tronick SR; Yaniv A; Gazit A
    Gene; 1994 Dec; 150(2):307-11. PubMed ID: 7821797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity.
    Carvalho M; Kirkland M; Derse D
    J Virol; 1993 Nov; 67(11):6586-95. PubMed ID: 8411361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies
    Wang XF; Liu Q; Wang YH; Wang S; Chen J; Lin YZ; Ma J; Zhou JH; Wang X
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.
    Rappaport J; Lee SJ; Khalili K; Wong-Staal F
    New Biol; 1989 Oct; 1(1):101-10. PubMed ID: 2562188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tat-induced lesions in transgenic mice do not correlate with the HIV-1 LTR transactivation.
    Fergelot P; Molina T; Blanchet P; Grimber G; Duquenne O; Couton D; Zider A; Briand P; Cavard C
    C R Acad Sci III; 1995 Mar; 318(3):329-37. PubMed ID: 7788501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.
    Maury W; Perryman S; Oaks JL; Seid BK; Crawford T; McGuire T; Carpenter S
    J Virol; 1997 Jul; 71(7):4929-37. PubMed ID: 9188555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional but not translational regulation of HIV-1 by the tat gene product.
    Rice AP; Mathews MB
    Nature; 1988 Apr; 332(6164):551-3. PubMed ID: 2833703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of the equine infectious anemia virus Tat-responsive element.
    Carvalho M; Derse D
    J Virol; 1991 Jul; 65(7):3468-74. PubMed ID: 1645778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Tat directly binds to NFkappaB enhancer sequence: role in viral and cellular gene expression.
    Dandekar DH; Ganesh KN; Mitra D
    Nucleic Acids Res; 2004; 32(4):1270-8. PubMed ID: 14981150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long terminal repeat sequences of equine infectious anaemia virus are a major determinant of cell tropism.
    Payne SL; La Celle K; Pei XF; Qi XM; Shao H; Steagall WK; Perry S; Fuller F
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():755-759. PubMed ID: 10092016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras.
    Carroll R; Martarano L; Derse D
    J Virol; 1991 Jul; 65(7):3460-7. PubMed ID: 1645777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.